Markets
← Back to Stocks
BAX
BAXTER INTERNATIONAL INC
Health Care · Health Care Equipment
$16.66
-2.52%
Vol: 0.2M
Araverus Market Read
Thursday, March 19, 2026
Baxter International down 0.25% pre-market as interim CFO appointment signals leadership transition amid 2026 guidance maintenance.
Baxter declined modestly in pre-market to $20.31 (-0.25%) and after-hours to $20.34 (-0.15%) following announcement that CFO Joel Grade departs March 16, 2026. The company appoints an interim CFO amid leadership transition while backing FY26 adjusted EPS guidance of $1.85-$2.05 (consensus $1.92). Barclays maintains Buy rating, providing some analyst support through the transition.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$8.6B
P/E (TTM)—
Forward P/E8.1
Beta0.55
Div Yield211.00%
Prev Close$17.09
RSI (14-Day)
21Oversold
0305070100
52-Week Range
$16.36$16.66$34.52
From High-51.7%
From Low+1.8%
Moving Averages
50d SMA
$19.77-15.7%
200d SMA
$22.58-26.2%
Price below 200d MA — bearish structure.
Returns
1W
-7.5%
1M
-23.8%
3M
-12.5%
6M
-28.1%
1Y
-51.1%
YTD
-14.5%
Volume
Today238K
20d Avg10.3M
Ratio0.02x